Bacillus Coagulans Market Analysis & Evolving Opportunities Studied for the Period Until 2028

Sales of bacillus coagulans have witnessed sheer proliferation in the recent past in line with rising consumer preference for probiotic diet and growing digestive disorders. The bacillus coagulans market is expected to witness sales surpassing 41 thousand tons by 2019, as per the latest research study by Fact.MR.

Interest in probiotic fortified functional foods and beverages continues to grow across countries. Exhibiting the characteristics of both lactobacillus and bacillus genera, bacillus coagulans has recently attracted the attention of food manufacturers and researchers. A large number of studies are being conducted on the low-cost microbial production of bacillus coagulans for use in the food industry.

According to Fact.MR’s report, cost-effectiveness and better stability and survival of bacillus coagulans in high-temperature, heat treated food products are the major factors fostering the adoption rate of bacillus coagulans in the food and beverages industry. Bacillus coagulans is being increasingly used in food supplements to strengthen the immune system, provide anti-allergy effect, and reduce gastrointestinal system infection.

Request Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2903

Recent studies have shown positive effects of probiotics such as bacillus coagulans, with a significant reduction in inflammation and acne-causing bacteria. Bacillus coagulans is witnessing growing demand in the cosmetic industry, owing to the immense benefits offered in managing skin problems and acne.

New formulations including Bacillus coagulans is being launched by cosmetics providers for anti-aging effects. These products include creams, lotions, face masks, scrubs, cleansers, and gels. Cosmetics product manufacturers are also focusing on developing cosmeceutical ingredients including bacillus coagulans to be used in various cosmetic products including powders, gels, face scrub, lotions, and creams.

Bacillus coagulans are also gaining popularity in managing and treating symptoms of eczema and atopic dermatitis. Its incorporation in cosmetic products including moisturizing cream and anti-acne face wash is also on a rise. Owing to is biological activity and protection of skin, bacillus coagulans is widely used in personal care products.

Health and wellness continues to be at the forefront of new product development strategies with new dairy-free probiotic foods hitting the market each year. There has been an increased demand for non-dairy probiotics owing to the rise in vegan and vegetarian population, desire for low milk cholesterol, a rise in milk protein allergies, and increased lactose intolerance.

Bacillus coagulans is emerging as the main ingredient in the majority of the dairy-free food products. Reported safe by the FDA and EFSA, bacillus coagulans is largely being added in functional food products and dairy-free probiotic supplements.

High stability of bacillus coagulans through processing and heating is leading to growing demand in heat-treated food products. Most of the products used in food industry that can be produced by Bacillus coagulans is gaining popularity due to the low cost and alternative to other harmful chemical sources.

Side-effects of Bacillus coagulans is very mild but carelessness in dosage can result in intestinal gas and bloating. There is an ongoing debate on potential risk and side-effects of bacillus coagulans because it is not naturally present in the digestive system. Various strains of bacillus coagulans have been identified that may not be safe to use as probiotics.

While bacillus coagulans may offer several benefits as compared to other probiotics, the research done on this probiotics is still limited. There is also a concern that spores produced by bacillus coagulans can move out of digestive tract and reach other parts. Hence, it is not recommended for people with immunocompromised conditions, or the person using a catheter as it may lead to bacterial infection.

In a clinical study published in Archives of Internal Medicine, bacillus coagulans infection was identified among patients with leukaemia, lymphoma, and breast cancer. Moreover, bacillus coagulans also interacts with certain drugs that may increase the risk of side-effects and affect immune function.

Have Any Query? Ask Our Industry Experts @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=2903

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/